Skip to main content
. 2019 Apr 22;22(2):185–195. doi: 10.4048/jbc.2019.22.e22

Figure 2. Effects of brief treatment with doxorubicin or paclitaxel on cell migration (A, C) and invasion (B, D) in BT-474 breast cancer cells (A, B) and ES-2 ovarian cancer cells (C, D). Cells were pretreated with paclitaxel (30 nM) for 1 hour, doxorubicin (200 nM or 800 nM) for 3 hours, or vehicle control and migration and invasion assays were performed.

Figure 2

*p < 0.05 versus control; p < 0.01.